Alnylam Pharmaceuticals, Inc. Forecast and Target Price
$246.75
Alnylam Pharmaceuticals, Inc. (ALNY) Share Price Forecast
Currently 34 wall-street analysts regularly analyze the financials of Alnylam Pharmaceuticals, Inc. on a frequent basis to provide recommendations along with target share price. 34 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals, Inc. (ALNY) have a share price target of $304.61. This median of share price forecast represents a 23.45% upside from the latest price of $246.75 as on 06.03.25.
Alnylam Pharmaceuticals, Inc. (ALNY) Price vs Consensus Price Target
As per the chart shown above, analysts believe that the Alnylam Pharmaceuticals, Inc. (ALNY) share price will touch around $304.61 in next 12-months.
Alnylam Pharmaceuticals, Inc. (ALNY) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Alnylam Pharmaceuticals, Inc.'s share price and its median forecast price. As on 06.03.25, the difference is -8.32%
Alnylam Pharmaceuticals, Inc. (ALNY): Difference between Current Price & Median Forecasted Price
Alnylam Pharmaceuticals, Inc. (ALNY) Share Price : Analyst Recommendation
Based on 34 analysts tracking and researching Alnylam Pharmaceuticals, Inc. (ALNY) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 17 | 16 | 16 |
| Outperform | 8 | 8 | 8 |
| Hold | 8 | 10 | 10 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |